How is the company contributing to fighting COVID-19?

Tattvan has launched the “Swastha Samarth” initiative and has pledged to support small-town doctors through their telemedicine application. Since most of the clinics and OPDs are closed during the lockdown period, regular chronic patients like diabetes, asthma, cancer, hypertension, etc are suffering due to lack of medical assistance. This initiative also supports employees and their family members of corporate who are partnered with Tattvan E-clinics. They will be provided with free consultation for up to 4 family members, during the national lockdown period.

How is COVID impacting the telemedicine sector? what lies ahead?

Over the years, India has seen considerable growth in the telemedicine sector however, the growth was not rapid due to the lack of proper guidelines and regulations. With the Ministry of Health approving the use of telemedicine in India amid coronavirus and publishing the guidelines regulating the same, the future growth and impact of telemedicine are to change by leaps and bounds.

India has always been a country with two faces, one of an Urban India and the other of a rural India. From the quality of life to quality of healthcare everything has a huge gap. During this pandemic and unavoidable situation, the delivery and facilitation of media health through telemedicine is important for the nation. The policy will not help to reduce the risk of transmission but also reduce the burden on medical practitioners to deal with numbers of patients suffering from asthma, diabetes, etc.

This scenario would take a complete 180-degree shift with the latest government regulations. Private players would now be more willing and enthusiastic in entering the market now without second-guessing the plausible results and expecting high investments from them as well. We believe that the telemedicine industry has a bright future and may become a multi-billion industry in the next 3-5 years.